Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-722,550
Closed -$18.5M 148
2024
Q1
$18.5M Buy
722,550
+127,630
+21% +$3.2M 0.16% 65
2023
Q4
$15.5M Buy
+594,920
New +$13.6M 0.15% 68
2023
Q1
Sell
-1,327,650
Closed -$20.4M 143
2022
Q4
$20.4M Sell
1,327,650
-315,157
-19% -$5.51M 0.4% 50
2022
Q3
$31.2M Buy
1,642,807
+456,772
+39% +$9.07M 0.66% 39
2022
Q2
$21.3M Sell
1,186,035
-97,686
-8% -$2.25M 0.64% 43
2022
Q1
$38.6M Buy
+1,283,721
New +$40M 0.91% 34
2020
Q4
Sell
-70,920
Closed -$2.96M 138
2020
Q3
$2.96M Buy
70,920
+13,530
+24% +$618K 0.05% 87
2020
Q2
$2.41M Buy
57,390
+12,820
+29% +$393K 0.05% 92
2020
Q1
$860K Buy
+44,570
New +$1.51M 0.02% 106

Other funds holding XP

Axiom Investors's XP Position: Q2 2024 in Review

Axiom Investors sold out of XP (XP) in Q2 2024, closing a stake of 722,550 shares — an estimated $18.5M sold.

Axiom Investors first reported a position in XP in Q1 2020 and held it in 9 quarters. The position peaked at $38.6M in Q1 2022. 265 funds tracked by Wall St. Rank hold XP as of Q2 2024.

  • Axiom Investors reported no remaining XP position as of Q2 2024 after selling out during the quarter.
  • Axiom Investors sold 722,550 XP shares in Q2 2024, an estimated $18.5M.
  • Axiom Investors first reported a position in XP in Q1 2020 and held it in 9 quarters.
  • Axiom Investors's XP position peaked at $38.6M in Q1 2022.
  • 265 funds tracked by Wall St. Rank held XP as of Q2 2024.

Based on Axiom Investors's 13F filing for Q2 2024, filed 13 Aug 2024.